Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$328M |
| 2 |
Johnson & Johnson
JNJ
|
+$229M |
| 3 |
GE Aerospace
GE
|
+$156M |
| 4 |
Target
TGT
|
+$155M |
| 5 |
Walt Disney
DIS
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$283M |
| 2 |
Eli Lilly
LLY
|
+$211M |
| 3 |
Microsoft
MSFT
|
+$199M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$184M |
| 5 |
Citigroup
C
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.03% |
| 2 | Healthcare | 12.1% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Consumer Staples | 11.92% |
| 5 | Industrials | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UN
201
DELISTED
Unilever NV New York Registry Shares
UN
| $44.1M | 0.11% |
+1,169,600
| New | +$46.2M |
|
202
Brown-Forman Class B
BF.B
$12.6B
| $44.1M | 0.11% |
2,023,516
+892,188
| +79% | +$20.1M |
|
203
Dillards
DDS
$8.96B
| $44M | 0.11% |
562,100
-278,600
| -33% | -$22.6M |
|
204
J.M. Smucker
SJM
$12.9B
| $44M | 0.11% |
418,803
+178,500
| +74% | +$19.3M |
|
205
W.W. Grainger
GWW
$66B
| $44M | 0.11% |
168,000
+121,500
| +261% | +$31.6M |
|
206
PPG Industries
PPG
$26.4B
| $43.5M | 0.11% |
520,800
-655,400
| -56% | -$52.4M |
|
207
Molson Coors Class B
TAP
$7.71B
| $43.3M | 0.11% |
863,600
+128,000
| +17% | +$6.44M |
|
208
Microchip Technology
MCHP
$42.3B
| $43.1M | 0.1% |
2,140,794
-572,600
| -21% | -$11.3M |
|
|
SPLK
209
DELISTED
Splunk Inc
SPLK
| $43.1M | 0.1% |
717,300
-127,900
| -15% | -$6.81M |
|
210
Ameren
AEE
$31B
| $42.8M | 0.1% |
1,228,000
-980,600
| -44% | -$34M |
|
|
CTRX
211
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $42.7M | 0.1% |
929,970
+878,200
| +1,696% | +$46.4M |
|
212
Toronto Dominion Bank
TD
$198B
| $42.5M | 0.1% |
944,180
+68,200
| +8% | +$2.9M |
|
|
MMP
213
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $42.5M | 0.1% |
752,716
+257,100
| +52% | +$14.1M |
|
214
Equifax
EFX
$20.8B
| $42.4M | 0.1% |
708,795
+404,900
| +133% | +$24.9M |
|
215
Phillips 66
PSX
$83.3B
| $42.3M | 0.1% |
+730,900
| New | +$42.4M |
|
216
Vale
VALE
$62.9B
| $42.2M | 0.1% |
2,703,900
-1,169,400
| -30% | -$17.3M |
|
|
SRCL
217
DELISTED
Stericycle Inc
SRCL
| $42.1M | 0.1% |
364,620
+177,900
| +95% | +$20.5M |
|
218
Becton Dickinson
BDX
$43.8B
| $42.1M | 0.1% |
+431,115
| New | +$42.2M |
|
219
Charles River Laboratories
CRL
$10.8B
| $41.9M | 0.1% |
906,209
-278,100
| -23% | -$12.8M |
|
220
Ciena
CIEN
$53.4B
| $41.7M | 0.1% |
1,668,505
+537,100
| +47% | +$12.1M |
|
221
Northrop Grumman
NOC
$77.8B
| $41.7M | 0.1% |
437,300
-158,900
| -27% | -$14.7M |
|
|
SEMG
222
DELISTED
SEMGROUP CORPORATION
SEMG
| $41.6M | 0.1% |
729,500
-23,400
| -3% | -$1.3M |
|
223
Service Corp International
SCI
$11.4B
| $41.5M | 0.1% |
2,227,500
+574,200
| +35% | +$10.7M |
|
224
Diageo
DEO
$47.3B
| $41.3M | 0.1% |
325,200
+286,400
| +738% | +$35.8M |
|
225
Infosys
INFY
$47.4B
| $41.3M | 0.1% |
6,870,400
+1,945,600
| +40% | +$11.5M |
|
Similar funds
Renaissance Technologies's Q3 2013 Portfolio in Review
As of Q3 2013, Renaissance Technologies held 3,196 positions worth $41.2B, up 8.1% from $38.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q3 2013 filing shows 439 new, 1,284 increased, 1,031 reduced and 412 closed positions. Its largest new stake was GE Aerospace: 1,361,721 shares worth $156M. The largest sale was Apple, an estimated $283M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q3 2013 buy was GE Aerospace: 1,361,721 shares worth $156M.
- Renaissance Technologies added most to IBM in Q3 2013, an estimated $328M increase.
- Renaissance Technologies's biggest Q3 2013 reduction was Eli Lilly, cutting an estimated $211M.
- Renaissance Technologies fully exited Apple in Q3 2013, selling an estimated $283M.
- Renaissance Technologies's ten largest holdings make up 11% of its $41.2B portfolio in Q3 2013.
- Renaissance Technologies opened 439 new positions and closed 412 in Q3 2013.
- Renaissance Technologies's portfolio value rose 8.1% quarter-over-quarter to $41.2B.
Based on Renaissance Technologies's 13F filing for Q3 2013, filed 13 Nov 2013.